ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,620,987 | -18.8% | 1,214,860 | 0.0% | 1.46% | -4.3% |
| Q2 2023 | $8,151,711 | -24.0% | 1,214,860 | 0.0% | 1.52% | -27.0% |
| Q1 2023 | $10,727,214 | +131.0% | 1,214,860 | +99.9% | 2.09% | +95.0% |
| Q4 2022 | $4,644,050 | -46.3% | 607,860 | -50.0% | 1.07% | -46.0% |
| Q3 2022 | $8,650,000 | -12.0% | 1,214,860 | 0.0% | 1.98% | -13.4% |
| Q2 2022 | $9,828,000 | -30.2% | 1,214,860 | +19.7% | 2.29% | -34.0% |
| Q1 2022 | $14,086,000 | -33.1% | 1,014,860 | +35.2% | 3.47% | -32.4% |
| Q4 2021 | $21,066,000 | +40.4% | 750,760 | +70.1% | 5.13% | +7.8% |
| Q3 2021 | $15,005,000 | +42.4% | 441,466 | +71.2% | 4.76% | +31.7% |
| Q2 2021 | $10,535,000 | +29.4% | 257,827 | +27.5% | 3.61% | +13.1% |
| Q1 2021 | $8,141,000 | +64.8% | 202,220 | +142.1% | 3.20% | +1.1% |
| Q4 2020 | $4,939,000 | – | 83,535 | – | 3.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |